Signal active
Organization
Contact Information
Overview
Affect Therapeutics offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. They provide treatments for a variety of substance use disorders. The program provides financial incentives to encourage healthy behaviors and new habits.
About
Health Care, Fitness, Wellness, Addiction Treatment
2020
51-100
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Affect Therapeutics headquartered in New York, New York, United States, North America, operates in the Health Care, Fitness, Wellness, Addiction Treatment sector. The company focuses on Health Care and has secured $1.5B in funding across 64 round(s). With a team of 51-100 employees, Affect Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series A - Affect Therapeutics, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
6
0
$23.0M
Details
4
Affect Therapeutics has raised a total of $23.0M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 1.0M | ||
2021 | Seed | 6.0M | ||
2023 | Early Stage Venture | |||
2023 | Early Stage Venture | 16.0M |
Investors
Affect Therapeutics is funded by 22 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
What If Ventures | - | FUNDING ROUND - What If Ventures | 16.0M |
Imran Hamid | - | FUNDING ROUND - Imran Hamid | 16.0M |
Affect Therapeutics | - | FUNDING ROUND - Affect Therapeutics | 16.0M |
LifeArc Ventures | - | FUNDING ROUND - LifeArc Ventures | 16.0M |
Recent Activity
There is no recent news or activity for this profile.